Literature DB >> 26167918

p39R861-4, A Type 2 A/C2 Plasmid Carrying a Segment from the A/C1 Plasmid RA1.

Sashindran Anantham1, Christopher J Harmer1, Ruth M Hall1.   

Abstract

The largest plasmid in the strain 39R861, which is used as a plasmid size standard, was recovered by conjugation and sequenced to determine its exact size. Plasmid p39R861-4 transferred at high frequency. Although reported to be the A/C1 plasmid RA1, p39R861-4 is a 155794-bp Type 2 A/C2 plasmid, in which a 39-kb segment, derived from RA1 that includes a relative of the RA1 resistance island, replaces 26.5 kb of the Type 2 backbone. p39R861-4 includes a single copy of IS10 and two resistance islands with a CR2-sul2 region in each of them. The 84 kb of backbone between the resistance islands is inverted relative to other known A/C plasmids and this inversion has arisen through recombination between the CR2-sul2 regions that are inversely oriented. The two resistance islands present before this inversion occurred were one related to but longer than that found in RA1, and one that is a form of the ARI-B island and identical to ARI-B in the A/C2 plasmid R55. They contain genes conferring resistance to tetracycline (tetA(D)), sulfonamides (sul2), and florfenicol and chloramphenicol (floR). The tet(D) determinant is flanked by two IS26 in a transposon-like structure named Tntet(D). Both resistance islands contain remnants of the two ends of the integrative element GIsul2, consistent with the sul2 gene being mobilized by GIsul2 rather than by CR2.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26167918     DOI: 10.1089/mdr.2015.0133

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Acinetobacter baumannii ATCC 19606 Carries GIsul2 in a Genomic Island Located in the Chromosome.

Authors:  Mohammad Hamidian; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

2.  Identification of IncA/C Plasmid Replication and Maintenance Genes and Development of a Plasmid Multilocus Sequence Typing Scheme.

Authors:  Steven J Hancock; Minh-Duy Phan; Kate M Peters; Brian M Forde; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; David L Paterson; Timothy R Walsh; Scott A Beatson; Mark A Schembri
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  IS26-Mediated Formation of Transposons Carrying Antibiotic Resistance Genes.

Authors:  Christopher J Harmer; Ruth M Hall
Journal:  mSphere       Date:  2016-04-06       Impact factor: 4.389

4.  Co-occurrence of 3 different resistance plasmids in a multi-drug resistant Cronobacter sakazakii isolate causing neonatal infections.

Authors:  Lining Shi; Quanhui Liang; Zhe Zhan; Jiao Feng; Yachao Zhao; Yong Chen; Mei Huang; Yigang Tong; Weili Wu; Weijun Chen; Xiaojun Li; Zhe Yin; Jinglin Wang; Dongsheng Zhou
Journal:  Virulence       Date:  2017-08-16       Impact factor: 5.882

5.  Structural Genomics of repA, repB 1-Carrying IncFIB Family pA1705-qnrS, P911021-tetA, and P1642-tetA, Multidrug-Resistant Plasmids from Klebsiella pneumoniae.

Authors:  Amina Nazir; Yachao Zhao; Manli Li; Rakia Manzoor; Rana Adnan Tahir; Xianglilan Zhang; Hong Qing; Yigang Tong
Journal:  Infect Drug Resist       Date:  2020-06-22       Impact factor: 4.003

6.  Spread of the florfenicol resistance floR gene among clinical Klebsiella pneumoniae isolates in China.

Authors:  Junwan Lu; Jinfang Zhang; Lei Xu; Yabo Liu; Pingping Li; Tingyuan Zhu; Cong Cheng; Shunfei Lu; Teng Xu; Huiguang Yi; Kewei Li; Wu Zhou; Peizhen Li; Liyan Ni; Qiyu Bao
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-01       Impact factor: 4.887

7.  The integrase of genomic island GIsul2 mediates the mobilization of GIsul2 and ISCR-related element CR2-sul2 unit through site-specific recombination.

Authors:  Gang Zhang; Qinna Cui; Jianjuan Li; Ruiliang Guo; Sébastien Olivier Leclercq; Lifeng Du; Na Tang; Yuqin Song; Chao Wang; Fangqing Zhao; Jie Feng
Journal:  Front Microbiol       Date:  2022-08-01       Impact factor: 6.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.